Show simple item record

dc.creatorDardiotis, E.en
dc.creatorGiamouzis, G.en
dc.creatorMastrogiannis, D.en
dc.creatorVogiatzi, C.en
dc.creatorSkoularigis, J.en
dc.creatorTriposkiadis, F.en
dc.creatorHadjigeorgiou, G. M.en
dc.date.accessioned2015-11-23T10:25:12Z
dc.date.available2015-11-23T10:25:12Z
dc.date.issued2012
dc.identifier10.1155/2012/595821
dc.identifier.issn20900597
dc.identifier.urihttp://hdl.handle.net/11615/26926
dc.description.abstractCognitive impairment (CI) is increasingly recognized as a common adverse consequence of heart failure (HF). Although the exact mechanisms remain unclear, microembolism, chronic or intermittent cerebral hypoperfusion, and/or impaired cerebral vessel reactivity that lead to cerebral hypoxia and ischemic brain damage seem to underlie the development of CI in HF. Cognitive decline in HF is characterized by deficits in one or more cognition domains, including attention, memory, executive function, and psychomotor speed. These deficits may affect patients' decision-making capacity and interfere with their ability to comply with treatment requirements, recognize and self-manage disease worsening symptoms. CI may have fluctuations in severity over time, improve with effective HF treatment or progress to dementia. CI is independently associated with disability, mortality, and decreased quality of life of HF patients. It is essential therefore for health professionals in their routine evaluations of HF patients to become familiar with assessment of cognitive performance using standardized screening instruments. Future studies should focus on elucidating the mechanisms that underlie CI in HF and establishing preventive strategies and treatment approaches. © Copyright 2012 Efthimios Dardiotis et al.en
dc.source.urihttp://www.scopus.com/inward/record.url?eid=2-s2.0-84863637384&partnerID=40&md5=3c9c7fd85ca7c1a4806c831b6b03c7e2
dc.subjectantiarrhythmic agenten
dc.subjectcardiotonic agenten
dc.subjectcholinesterase inhibitoren
dc.subjectdigoxinen
dc.subjectdipeptidyl carboxypeptidase inhibitoren
dc.subjectdiuretic agenten
dc.subjectAlzheimer diseaseen
dc.subjectartificial heart pacemakeren
dc.subjectattentionen
dc.subjectblood vessel reactivityen
dc.subjectbradycardiaen
dc.subjectbrain hypoxiaen
dc.subjectbrain ischemiaen
dc.subjectbrain perfusionen
dc.subjectcognitive defecten
dc.subjectcognitive rehabilitationen
dc.subjectdecision makingen
dc.subjectdementiaen
dc.subjectdepth perceptionen
dc.subjectdisabilityen
dc.subjectdisease severityen
dc.subjectexecutive functionen
dc.subjectheart failureen
dc.subjectheart transplantationen
dc.subjectlanguage disabilityen
dc.subjectmemoryen
dc.subjectmicroembolismen
dc.subjectmortalityen
dc.subjectmultiinfarct dementiaen
dc.subjectpathophysiologyen
dc.subjectphysical activityen
dc.subjectpriority journalen
dc.subjectpsychomotor performanceen
dc.subjectreviewen
dc.subjectself careen
dc.subjecttranscranial magnetic stimulationen
dc.subjectworking memoryen
dc.titleCognitive impairment in heart failureen
dc.typejournalArticleen


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record